Abstract
Objective:
The purpose of this study is to validate the 4P's Plus screen for substance use in pregnancy.
Study Design:
A total of 228 pregnant women enrolled in prenatal care underwent screening with the 4P's Plus and received a follow-up clinical assessment for substance use. Statistical analyses regarding reliability, sensitivity, specificity, and positive and negative predictive validity of the 4Ps Plus were conducted.
Result:
The overall reliability for the five-item measure was 0.62. Seventy-four (32.5%) of the women had a positive screen. Sensitivity and specificity were very good, at 87 and 76%, respectively. Positive predictive validity was low (36%), but negative predictive validity was quite high (97%). Of the 31 women who had a positive clinical assessment, 45% were using less than 1 day per week.
Conclusion:
The 4P's Plus reliably and effectively screens pregnant women for risk of substance use, including those women typically missed by other perinatal screening methodologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lester BM, Corwin MJ, Sepkoski C, Seifer R, Peucher M, McLaughlin S et al. Neurobehavioral syndromes in cocaine-exposed newborn infants. Child Dev 1991; 62: 694–705.
Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA . Temporal patterns of cocaine use in pregnancy. J Am Med Assoc 1989; 741–1744.
Finnegan LP, Connaughton JF, Kron RE, Samuels SJ, Batra KK . Neonatal abstinence syndrome: assessment and management. In: Harbison RD (ed). Perinatal Addiction. Spectrum Publications: New York, 1975 pp 141–158.
Streissguth AP, Sampson P, Barr H . Neurobehavioral dose–response effects of prenatal alcohol exposure in humans from infancy to adulthood. Ann NY Acad Sci 1989; 562: 145–158.
Fried PA, Watkinson B . 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. J Dev Behav Pediatr 1990; 11 (2): 49–58.
American College of Obstetricians and Gynecologists. Substance abuse in pregnancy. ACOG Technical Bulletin No. 195. American College of Obstetricians and Gynecologists: Washington (DC), 1994.
Perl HI . Numerous Studies Demonstrate Effectiveness of Brief Interventions. NIAAA: Frontlines Washington DC, 2000.
US preventive services task force ratings: strength of recommendations and quality of evidence. Guide to Clinical Preventive Services, Third Edition: Periodic Updates 2000–2003. Agency for Healthcare Research and Quality: Rockville, MD##http://www.ahrq.gov/clinic/3rduspstf/ratings.htm.
Chasnoff IJ, Neuman K, Thornton C, Callaghan MA . Screening for substance use in pregnancy: a practical approach for the primary care physician. Am J Obstet Gynecol 2001; 184: 752–758.
Ewing J . Detecting alcoholism: the CAGE questionnaire. JAMA 1984; 252: 1905–1907.
Kitchens JM . Does this patient have an alcohol problem? JAMA 1994; 272: 1782–1787.
Bottoms SF, Martier SS, Sokol RJ . Refinements in screening for risk drinking in reproductive-aged women: the ‘NET’ results. Alcohol Clin Exp Res 1989; 13: 339.
Sokol RJ, Martier SS, Ager JW . The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989; 160: 863–868.
Russsell M, Martier SS, Sokol RJ, Mudar P, Bottoms S, Jacobson S et al. Screening for pregnancy risk-drinking: TWEAKing the tests. Alcohol Clin Exp Res 1991; 15: 368 abstract no. 338.
Chan AW, Pristach EA, Welte JW, Russell M . Use of the TWEAK test in screening for alcoholism/heavy drinking in three populations. Alcohol Clin Exp Res 1993; 17: 1188–1192.
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA . The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med 1998; 158: 1789–1795.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV: International Version with ICD-10 Codes 1995.
Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T et al. Prenatal alcohol exposure and childhood behavior at age 6–7 years: I. Dose–response effect. Pediatrics 2001; 108: e34.
Chasnoff IJ, Hung WC . The 4P's Plus. NTI Publishing: Chicago, 1999.
Chasnoff IJ, McGourty RF, Bailey GF, Hutchins E, Lightfoot SO, Pawson LL et al. The 4P's Plus© screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 2005; 368–374.
Hutchins E, DiPietro J . Psychosocial risk factors associated with cocaine use during pregnancy: a case–control study. Obstet Gynecol 1997; 90: 142–147.
Center for Substance Abuse Prevention. Maternal Substance Use Assessment Methods Reference Manual: A Review of Screening and Clinical Assessment Instruments for Examining Maternal Use of Alcohol, Tobacco, and Other Drugs, (DHHS Publication no. (SMA) 93–2059) Division of Communication Programs: Rockville, MD, 1993.
Larrson G . Prevention of fetal alcohol effects: an antenatal program for early detection of pregnancies at risk. Acta Obstet Gynecol Scand 1983; 62: 171–178.
Little RE, Young A, Streissguth AP, Uhl CN . Preventing fetal alcohol effects: effectiveness of a demonstration project In: CIBA Foundation Symposium 105, Mechanisms of Alcohol Damage In Utero. Pitman Press: London, 1984 pp 254–274.
Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA . Temporal patterns of cocaine use in pregnancy: perinatal outcome. JAMA 1989; 261: 1741–1744.
Armstrong MA, Osejo VG, Lieberman L, Carpenter DM, Pantoja PM, Escobar GJ . Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol 2003; 23: 3–9.
Huizink AC, Mulder EJH . Maternal smoking, drinking, or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Behav Rev 2006; 30: 24–41.
Roche AM, Richard GP . Doctors' willingness to intervene in patients' drug and alcohol problems. Soc Sci Med 1991; 33: 1053–1061.
ACOG Committee on Ethics. At-risk drinking and illicit drug use: Ethical issues in obstetric and gynecologic practice. ACOG Committee Opinion No. 294. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004; 103: 1021–1031.
Acknowledgements
This work was supported in part by a grant from Maternal and Child Health Bureau, Health Resources and Services Administration, US Department of Health and Human Services no. D63MC00053.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chasnoff, I., Wells, A., McGourty, R. et al. Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus. J Perinatol 27, 744–748 (2007). https://doi.org/10.1038/sj.jp.7211823
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211823
Keywords
This article is cited by
-
Development and validation of the Cannabis Exposure in Pregnancy Tool (CEPT): a mixed methods study
BMC Pregnancy and Childbirth (2024)
-
Listening to Black Pregnant and Postpartum People: Using Technology to Enhance Equity in Screening and Treatment of Perinatal Mental Health and Substance Use Disorders
Journal of Racial and Ethnic Health Disparities (2024)
-
Screening for Alcohol Use in Pregnancy: a Review of Current Practices and Perspectives
International Journal of Mental Health and Addiction (2023)
-
Intrauterine Drug Exposure—What the Pediatrician Needs to Know. Part 1: General Overview, Transplacental Drug Transfer, Teratogenicity, and Fetal Alcohol Spectrum Disorder
Current Treatment Options in Pediatrics (2023)
-
The Effect of Maternal Adverse Childhood Experiences (ACEs) on Substance Use During Pregnancy
Maternal and Child Health Journal (2023)